Xiaochun Zhang
No más puestos en curso
Fortuna: 117 600 $ al 30/04/2024
Perfil
Xiaochun Zhang worked as a General Manager for Dragon Pharmaceutical, Inc., as a Deputy General Manager for Aurobindo Bio Pharma Co. Ltd.
and Zhangjiakou Pharmaceutical Co., and as a General Manager for GIST-Biocades Pharmaceutical Co. Ltd.
Mr. Zhang obtained an undergraduate degree from Hebei University of Science & Technology.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
TANTECH HOLDINGS LTD.
6.07% | 25/07/2023 | 210 000 ( 6.07% ) | 117 600 $ | 30/04/2024 |
Antiguos cargos conocidos de Xiaochun Zhang.
Empresas | Cargo | Fin |
---|---|---|
GIST-Biocades Pharmaceutical Co. Ltd. | Corporate Officer/Principal | - |
Aurobindo Bio Pharma Co. Ltd. | Corporate Officer/Principal | - |
Zhangjiakou Pharmaceutical Co. | Corporate Officer/Principal | - |
Dragon Pharmaceutical, Inc.
Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - |
Formación de Xiaochun Zhang.
Hebei University of Science & Technology | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Dragon Pharmaceutical, Inc.
Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Health Technology |
Aurobindo Bio Pharma Co. Ltd. | |
Zhangjiakou Pharmaceutical Co. | |
GIST-Biocades Pharmaceutical Co. Ltd. |
- Bolsa de valores
- Insiders
- Xiaochun Zhang